IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2020 Earnings Conference Call July 31, 2020 8:30 AM ET Company Participants Brian McKeon - Chief Financial Officer Jay Mazelsky - President and Chief Executive Officer Conference Call Participants Michael Ryskin - Bank of America Nathan Rich - Goldman Sachs Jon Block - Stifel David Westenberg - Guggenheim Securities Andrew Cooper - Raymond James Operator Good morning and welcome to the IDEXX Laboratories Second Quarter 2020 Earnings Conference Call. As a reminder, t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) (State o ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2020 Results Earnings Conference Call April 30, 2020 8:30 AM ET Company Participants Jay Mazelsky - President and CEO Brian McKeon - Chief Financial Officer John Ravis - Senior Director, Investor Relations Conference Call Participants Michael Ryskin - Bank of America Erin Wright - Credit Suisse Jon Block - Stifel Ryan Daniels - William Blair Nathan Rich - Goldman Sachs David Westenberg - Guggenheim Securities Andrew Cooper - Raymond James Operator Good morning. And ...

IDEXX Laboratories, Inc. Raymond James 41st Annual Institutional Investors Conference Jay Mazelsky Chief Executive Officer March 2, 2020 IDEXX Safe Harbor Disclaimer The following information contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 0-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) (State or other ju ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2019 Earnings Conference Call January 31, 2020 8:30 AM ET Company Participants Brian McKeon - CFO, EVP & Treasurer Jonathan Mazelsky - President, CEO & Director Conference Call Participants Nathan Rich - Goldman Sachs Group Ryan Daniels - William Blair & Company Michael Ryskin - Bank of America Merrill Lynch Jonathan Block - Stifel, Nicolaus & Company Erin Wright - Crédit Suisse Andrew Cooper - Raymond James & Associates David Westenberg - Guggenheim Securities Oper ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2019 Results Earnings Conference Call October 31, 2019 8:30 AM ET Company Participants Jay Mazelsky - President and CEO Brian McKeon - Chief Financial Officer John Ravis - Senior Director, Investor Relations Conference Call Participants Michael Ryskin - Bank of America Ryan Daniels - William Blair Erin Wright - Credit Suisse Nathan Rich - Goldman Sachs David Westenberg - Guggenheim Securities Jon Block - Stifel, Nicolaus & Co., Inc. Mark Massaro - Canaccord Operator ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) (Sta ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2019 Earnings Conference Call August 1, 2019 8:30 AM ET Company Participants Jay Mazelsky – Interim President and Chief Executive Officer Brian McKeon – Chief Financial Officer Conference Call Participants Michael Ryskin – Bank of America Ryan Daniels – William Blair Erin Wright – Credit Suisse Jon Block – Stifel Mark Massaro – Canaccord Genuity David Westerberg – Guggenheim Securities Andrew Cooper – Raymond James Michael Ryskin – Bank of America Operator Good morn ...